INSUBCONTINENT EXCLUSIVE:
ETMarkets.com|Updated: Jan 07, 2020, 09.19 AM ISTThinkStock PhotosBuy - sell ideasIndependent Analyst Kunal Bothra has a buy call on Dr
with a target price of Rs 2980
Kunal Bothra recommended to keep a stop loss at Rs 2855
Reddy's Laboratories Ltd., incorporated in the year 1984, is a Large Cap company (having a market cap of Rs 47837.02 Crore) operating in
key Products/Revenue Segments include Pharmaceuticals which contributed Rs 10466.70 Crore to Sales Value (98.50 % of Total Sales), Licence
Fees which contributed Rs 55.90 Crore to Sales Value (0.52 % of Total Sales), Service Income which contributed Rs 50.30 Crore to Sales Value
(0.47 % of Total Sales), Spent Chemicals which contributed Rs 35.60 Crore to Sales Value (0.33 % of Total Sales), Scrap which contributed Rs
16.10 Crore to Sales Value (0.15 % of Total Sales) and Other Operating Revenue which contributed Rs .90 Crore to Sales Value for the year
For the quarter ended 30-09-2019, the company has reported a Consolidated sales of Rs 4800.80 Crore, up 24.90 % from last quarter sales of
Rs 3843.60 Crore and up 30.22 % from last year same quarter sales of Rs 3686.60 Crore
Company has reported net profit after tax of Rs 1095.10 Crore in latest quarter
Sell Biocon, target Rs 270: Kunal BothraBuy NMDC, target Rs 120: Kunal BothraBuy Lupin, target Rs 777: Kunal BothraBuy Lupin, target Rs
782: Kunal BothraBuy Lupin, target Rs 805: Kunal BothraCommenting feature is disabled in your country/region.Disclaimer: This recommendation
is analyst's own and does not represent those of economictimes.com - ETMarkets.com
Please consult your financial advisor before taking any position in the stock/s mentioned.
